Trials / Recruiting
RecruitingNCT06423690
First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System
Snipe Medical First In Human Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Snipe Medical · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective, open label, multi center, single arm, First in Human study to assess the safety and initial performance of EAS1 system for Irreversible Electroporation (IRE) ablation of lung cancer in subjects eligible for tumor resection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EAS1 System | tumor ablation system in IRE method |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-05-15
- Completion
- 2025-07-15
- First posted
- 2024-05-21
- Last updated
- 2024-12-10
Locations
3 sites across 3 countries: Israel, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT06423690. Inclusion in this directory is not an endorsement.